drugset / Trial / NCT03976544

Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients

NCT03976544

Phase 4 Terminated 362 enrolled CRG UZ Brussel
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the current study is to compare miscarriage rates (before 8 weeks) between a true natural cycle (awaiting spontaneous LH surge) and a hormone replacement therapy cycle prior to blastocyst transfer in preimplantation genetic testing (PGT) patients, with biopsy on day 5 of embryonic development. The advantage of performing the study in PGT patients is the exclusion of aneuploidy as a cause of miscarriage.

Timeline

Start
2019-05-25
Primary completion
2025-01-01
Completion
2025-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 200 mg
Subject estradiol valerate Unknown 2 mg